Literature DB >> 1409491

Anticarcinogenic effects of (-)-epigallocatechin gallate.

H Fujiki1, S Yoshizawa, T Horiuchi, M Suganuma, J Yatsunami, S Nishiwaki, S Okabe, R Nishiwaki-Matsushima, T Okuda, T Sugimura.   

Abstract

BACKGROUND: Our research objective is to develop nontoxic cancer chemopreventive agents and to apply these agents in treating humans. We are identifying agents that inhibit the process of tumor promotion in two-stage carcinogenesis experiments on mouse skin.
METHODS: We review (a) the inhibitory effect of penta-O-galloyl-beta-D-glucose (5GG) on tumor promotion by teleocidin, one of the 12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters (5GG is structurally similar to (-)-epigallocatechin gallate (EGCG) and is isolated from hydrolyzed tannic acid); (b) the inhibitory effects of EGCG, the main constituent of Japanese green tea, on tumor promotion with two tumor promoters, teleocidin and okadaic acid, a non-TPA-type tumor promoter; (c) the mechanisms of action of EGCG, a single application of which reduced the specific binding of [3H]TPA and [3H]okadaic acid to a particulate fraction of mouse skin; and (d) the anticarcinogenic effects of EGCG on duodenal carcinogenesis induced by N-ethyl-N'-nitro-N-nitrosoguanidine in male C57BL/6 mice. EGCG is a nontoxic compound.
CONCLUSION: We believe that the main constituent of Japanese green tea, EGCG, is a practical cancer chemopreventive agent available in everyday life.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409491     DOI: 10.1016/0091-7435(92)90057-o

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.637


  14 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7.

Authors:  Zhiwei Zhong; Zhuo Dong; Lihua Yang; Xiaoqiang Chen; Zhaohui Gong
Journal:  Exp Ther Med       Date:  2012-05-17       Impact factor: 2.447

Review 3.  The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges.

Authors:  Mary Ndiaye; Carol Philippe; Hasan Mukhtar; Nihal Ahmad
Journal:  Arch Biochem Biophys       Date:  2011-01-04       Impact factor: 4.013

4.  Dietary chemoprevention of clastogenic effects of 3,4-benzo(a)pyrene by Emblica officinalis Gaertn. fruit extract.

Authors:  P Nandi; G Talukder; A Sharma
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.

Authors:  Koichi Saeki; Norihiko Kobayashi; Yuko Inazawa; Hong Zhang; Hideki Nishitoh; Hidenori Ichijo; Kumiko Saeki; Mamoru Isemura; Akira Yuo
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

6.  Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols.

Authors:  Madhulika Singh; Shilpa Tyagi; Kulpreet Bhui; Sahdeo Prasad; Yogeshwer Shukla
Journal:  Invest New Drugs       Date:  2009-03-07       Impact factor: 3.850

7.  Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases.

Authors:  K Imai; K Nakachi
Journal:  BMJ       Date:  1995-03-18

8.  Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Authors:  Anne S Tsao; Diane Liu; Jack Martin; Xi-ming Tang; J Jack Lee; Adel K El-Naggar; Ignacio Wistuba; Kirk S Culotta; Li Mao; Ann Gillenwater; Yuko M Sagesaka; Waun K Hong; Vassiliki Papadimitrakopoulou
Journal:  Cancer Prev Res (Phila)       Date:  2009-11

9.  Protective effect of (-)-epigallocatechin-3-gallate on capsaicin-induced DNA damage and oxidative stress in human erythrocyes and leucocytes in vitro.

Authors:  Dilek Pandır
Journal:  Cytotechnology       Date:  2014-04-13       Impact factor: 2.058

Review 10.  Why bortezomib cannot go with 'green'?

Authors:  Li Jia; Feng-Ting Liu
Journal:  Cancer Biol Med       Date:  2013-12       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.